Editorial Board

 His research interest includes Crop sciences and technology.

Rakesh Kumar Tiwari is pursuing his Ph.D. in Organic and Medicinal Chemistry.He is presently working as an assistant professor of biomedical sciences at Chapman University.He received many awards for his excellence in the field of medical and organic chemistry.

Application of peptides in nanomaterial’s and designing of drug conjugates for efficient drug delivery; Folate-mediated anticancer drug delivery to the cancer cells; Designing of CN2097 analogue and peptidomimetic for the treatment of neurodegenerative disease and treatment of stroke.

 His research interests include Material sciences,Plasma Physics, Nanotechnology.

Dr. Sanaa is presently working as an assistant professor for biomedical sciences in the department of therapeutic chemistry at National Research Centre Egypt

Her research interests includes biomedical sciences-biochemistry,histochemistry,proteins and histopathology

Dr. Dahl is CEO, President, and Founder of Neurodon LLC. Neurodon is developing breakthrough therapies for Alzheimer’s and Parkinson’s disease, having recently discovered small molecules that show efficacy in animal models for both diseases. In addition to his leadership at Neurodon, Dr. Dahl also currently serves as a Director of a specialty biotechnology company in New York and a consulting Global Vice President of an international drug discovery company in China. Previously, he led all small molecule drug discovery efforts for Celladon Corporation, a clinical-stage public biotechnology company. Prior to his pursuit of entrepreneurial drug discovery, Dr. Dahl held multiple leadership roles in Big Pharma, including stints at DuPont Pharmaceuticals, Bristol-Myers Squibb, and Vertex Pharmaceuticals. During his tenure here, he contributed to the discovery of multiple clinical drug candidates for all major diseases. A prolific multidisciplinary and entrepreneurial scientist, he has also founded or been involved in the founding of multiple startup biotech companies. Dr. Dahl has also held a post as a tenure track professor of Medicinal Chemistry and Drug discovery at a prestigious medical school and is a highly regarded lecturer. Dr. Dahl has co-authored over 70 peer-reviewed manuscripts and is an inventor on over 20 patents in therapeutics and chemistry. In his spare time, Dr. Dahl is an ardent admirer of Wrightian architecture, both pre- and post-Prairie School, having himself incorporated Usonian design philosophies in his private residence. A multi-instrumentalist, Dr. Dahl enjoys listening to and playing music from the Baroque and Post-modern time periods.

Drug Discovery, Pharmaceutics

Dr. Rao received his PhD from one of the topnotch pharmacy schools in India, University College of Pharmaceutical Sciences, Kakatiya University, Andhra Pradesh, India. He taught human anatomy, physiology and pharmacology to BS pharmacy students for more than 3 years. Post PhD, he worked for Drug Discovery and Development giants, Lupin Research Park, Lupin Limited, and Advinus Therapeutics Pvt. Ltd., Pune, India in Drug Metabolism and Pharmacokinetics (DMPK) division from 2006 to 2010. He began with the Dr. Bala Ambati lab in 2010, as a Postdoctoral Fellow, and continuing his research activities as Director, Pharmacology and Pharmacokinetics, iVeena LLC, and as Research Associate at John A Moran Eye Center, University of Utah. Dr. Rao is playing a key role in design and development of a novel Bioerodible Dexamethasone Implants (BDI) to provide targeted (local) and sustained release of dexamethasone during the critical postoperative time period, thus eliminating the need for topical steroid drops after cataract surgery. Dr. Rao is the co-inventor on 2 patents and published several papers in international peer-reviewed journals and his work is cited in the biomedical literature by colleagues all over the world. Dr. Rao is a peer reviewer for more than ten international journals and serving in the editorial and advisory boards of several pharmaceutical and bio-medical journals.

Design and development of a novel Bioerodible Dexamethasone Implants (BDI)

1.Actively involved in the design and syntheses of interesting biologically active nucleoside (oxygen, sulfur, selenium and carbocyclic) analogues for antiviral and anticancer applications. 2. Development of novel fluorinated carbocyclic nucleosides for antiviral applications (HBV/ HCV) – current work. 3.Design and first synthesis of novel DNA building blocks, 4′-selenothymidine and 4′-seleno-AZT as a potential antiviral agent from 2-deoxy-D-ribose (~15 steps, Org. Lett., 2010) 4.Improved Synthesis of a DNA-dependent Protein Kinase Inhibitor IC86621 (Arch. Pharm. Res., 2012) 5.Design and first synthesis of novel RNA purine and pyrimidine building blocks, (Chem. Eur. J., 2013, Eur. J. Med. Chem., 2014, Arch. Pharm. Res., 2015)

• Greener methodologies for halogen (iodine and fluorine) incorporation reactions; • Applications of supported reagents, heterogeneous catalysts, ionic liquids and unconventional methodologies like microwave assisted reaction or ultrasonic techniques in organic syntheses; • Development of novel nucleosides, nucleotides, prodrugs and carbohydrate chemistry; • Antiviral drug discovery (HIV, Hepatitis B & C, West Nile, Ebola, RSV); • Development of anti-cancer agents, adenosine receptor targets, heat shock protein targets, etc.; • Structure-based drug design and molecular modelling;

My name is Cristian-Catalin Gavat from Iasi, Romania.I want to mention that I am pharmacist and also chemical engineer, I own 2 qualifications. I also hold a Ph.D. in Medical Sciences, Pharmacy field, on the analytical chemistry specialization.Peer Reviewer activity carried out from December 11, 2018 to the present. I have peer reviewed over 240 completed articles which belonged to 20 scientific journals quoted / indexed Thompson Reuters Web of Science.

Inorganic Chemistry, Coordination Chemistry, Pharmacy and Pharmacology, Pharmaceutical Chemistry, Pharmaceutical and Medicinal Chemistry, Organic Chemistry, Biochemistry, Chemical Instrumental Analysis, Chemical Organic Synthesis, Polymer Chemistry, Natural and Synthetic Biopolymers, Pharmacy and Pharmaceutical Sciences, Pharmacology, Immunology, Nursing, Parasitology, Bioinformatics, Biomaterials, Analytical Chemistry, UV Sample Irradiation, UV-VIS and IR Spectroscopy analysis, NMR, FTIR and RAMAN Spectroscopy, Electrochemical Analysis Techniques, Potentiometry, Conductometry, Electrolysis, Voltammetry, Coulometry, Atomic Spectroscopy Analysis, Mass Spectrometry Analysis, Chromatographic Methods of Separation and Analysis. Electrophoretic Methods of Analysis: Capillary Electrophoresis, Discontinuous Electrophoresis. Qualitative and Quantitative Chemical Analysis of Drugs. Bioengineering and Biotechnologies.